| CYSB2100018 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2022-01-19 | view |
| CYSB2100019 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2022-01-19 | view |
| JYSB2000608 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| JYSB2000606 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| JYSB2000610 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| JYSB2000609 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| CXSS2000052 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | New Drug Application | 2020-10-15 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2021-11-02 | view |
| JYSB2000607 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-10-21 | view |
| CYSB2000380 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-23 | 赛诺菲（北京）制药有限公司 | Sanofi (Beijing) Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-18 | view |
| CYSB2000379 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-23 | 赛诺菲（北京）制药有限公司 | Sanofi (Beijing) Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-18 | view |
| CYSB2000405 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-01 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2021-08-24 | view |
| JXSS2000064 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Import Drug Application | 2020-12-23 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | In Review | 2021-05-09 | view |
| JYSB2100052 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-02-23 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JYSB2100022 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-18 | view |
| JYSB2100023 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-18 | view |
| JYSB2000624 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-12-25 | view |
| JXSS2000065 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Import Drug Application | 2020-12-23 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | In Review | 2020-12-22 | view |
| CYSB2000360 | 重组甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(原7) | Supplementary Application | 2020-12-18 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-12-16 | view |
| CYSB2000359 | 重组甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(原7) | Supplementary Application | 2020-12-18 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-12-16 | view |
| CXSS2000058 | 重组甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.4) | New Drug Application | 2020-11-27 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | In Review | 2020-11-26 | view |
